Incidence of cochlear involvement in hyperbilirubinemic deafness


Oysu Ç. , Ulubil A., Aslan I., Baserer N.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, cilt.111, sa.11, ss.1021-1025, 2002 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 111 Konu: 11
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1177/000348940211101113
  • Dergi Adı: ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
  • Sayfa Sayıları: ss.1021-1025

Özet

Neonatal hyperbilirubinemia remains an important cause of childhood deafness, especially in developing countries. After neonatal hyperbilirubinemia, the auditory neural pathways, cochlea, or both may be affected. In this study, we aimed to determine the incidence of cochlear impairment and the appropriate means of hearing screening in hyperbilirubinemic neonates. A retrospective review of 1,032 pediatric patients with hearing loss revealed 67 cases (6.5%) of severe hyperbilirubinemia in the neonatal period. Thirty of these patients had neonatal hyperbilirubinemia as the single identifiable risk factor for hearing loss. In 26 of 30 cases (87%), otoacoustic emissions (OAEs) were absent, whereas in the remaining 4 cases (13%), robust emissions were detected despite an absent auditory brain stem response (ABR). Auditory screening of newborns with jaundice by OAEs possesses a significant risk of undiagnosed deafness. On the other hand, if the ABR is used as the single means of screening, auditory neuropathic conditions will probably be underlooked. Therefore, we recommend dual screening of hearing by ABR and OAEs in hyperbilirubinemic newborns.